AT
Amicus Therapeutics Inc
🇺🇸XNAS.FOLDUnited StatesHealthcare
$14.49USDdown -0.01 (-0.07%)OpenEnd of day3:16 PM
Price$14.49-0.01 (-0.07%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03152W1099
- CUSIP
- 03152W109
Company
- Employees
- 511
- Headquarters
- Princeton, United States
- Website
- https://amicusrx.com
- CEO
- Mr. Bradley L. Campbell M.B.A.
Market
- Shares outstanding
- 314M
- Market cap
- $4.55B
Highlights
No high and low reported for today's session.
- Market cap
- $4.55B
- EPS LTM
- -$0.09calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -167.83calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $634.21M+20.05%up year on year
- Net income
- -$27.11M+51.68%up year on year
- Gross margin
- 87.91%-2.3%down year on year
- Free cash flow
- $29.85M+179.72%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.